Dr. Sarah R. Perloff, DO

Dr. Perloff practices at Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Perloff's NPI, 1023225869, was assigned on May 17, 2007. Dr. Perloff graduated from Rowan-Virtua School of Osteopathic Medicine - Stratford in 2002. Dr. Perloff holds Pennsylvania license OS014116.

Dr. Perloff's primary practice is Jefferson Einstein Philadelphia Hospital, at 5501 Old York Road, Philadelphia, PA 19141 in Philadelphia County. The practice phone is (215) 456-6090.

Dr. Perloff's primary practice is Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. The medical group on file is Einstein Gastroenterology Associates. Dmand AI also links Dr. Perloff to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perloff practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Perloff's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Perloff is board certified in infectious disease by the American Board of Internal Medicine. Dr. Perloff is licensed in Pennsylvania.

Dmand AI lists hiv/aids, pneumonia and UTI among the conditions Dr. Perloff treats.

CMS data shows 259 Medicare services from Dr. Perloff across 4 procedure codes in 2024, for 105 Medicare patients. Medicare paid $22,599 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 105 Medicare patients who saw Dr. Perloff in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 5.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perloff's median patient age at 64, with 46% women.

In 2024, Dr. Perloff wrote 33 Medicare Part D claims for 14 patients. 88% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $104 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

Dr. Perloff accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Perloff, published from 2015 to 2023. 2016 was the busiest year, with 4. The most frequent topics are Cross Infection, Infection Control and Mycobacterium tuberculosis. Dr. Perloff has published most often in Infect Dis Clin North Am. Dr. Perloff's most frequent co-authors are Percy Guanzon Balderia, MD, Ramzi Hani Mulki, MD and Yaser Alhamshari, MBBS.

CMS Open Payments shows 6 general payments to Dr. Perloff from 3 drug and device companies from 2016 to 2024. Education make up the largest share, 68% of the total. Astellas Pharma US Inc paid the most, $230.

Dr. Perloff graduated from Rowan-Virtua School of Osteopathic Medicine - Stratford in 2002. Dr. Perloff is a member of American Association of HIV medicine, ACP, AOA and IDSA.

Dr. Perloff is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.